M
Medimaps Group
Innovative swiss based company that is developing seamless solutions for clinical routine
About Medimaps Group
Medimaps Group specializes in developing advanced medical imaging software, primarily focusing on bone quality assessment and fracture risk prediction. Their flagship product, TBS iNsight, is a medically approved software that enhances the diagnostic capabilities of DXA bone densitometers, making it the gold standard in bone microarchitecture assessment for osteoporosis. The company serves healthcare providers, including hospitals, clinics, and dental practices, by offering solutions that improve patient management and therapy decisions. Operating in the global healthcare market, Medimaps Group generates revenue through the sale and licensing of their software products, as well as offering trials and support services. The business model is centered on continuous innovation and expansion into new markets, ensuring their technology remains at the forefront of medical imaging advancements.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- Plan-les-Ouates, Switzerland
- Employees
- 69
- Open positions
- 3
- Dealroom signal
- 68.1/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Risk Management, Medical Imaging, Core AI, Tech for Hospitals and Clinics, Clinical Decision Support, Tech for Medical Professionals, AI for medical imaging
- Technology
- Artificial Intelligence, Machine Learning, Deep Learning
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 1 company, latest Mar 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
Latest news
Press, funding announcements and product moves mentioning Medimaps Group.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Dec 2021 | $20M | $80M | Verve Ventures · Swiss Entrepreneurs Foundation · Swisscom Ventures · Swisscanto Invest | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Medimaps Group is 4.9K monthly website visits, down 12.5% over the last three months. Medimaps Group's team declined 5.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 MVision AIOffers solution for modern cancer radiation therapy treatment through innovative AI technology |
Helsinki, Finland | Operational | 60 | $8.3M | $24M |
 Keen EyeAnalyzes and reviews slide images |
Paris, France | Closed | |||
 CardioLogsDemocratizes expert cardiac care globally, by empowering all actors in the care chain with AI |
Paris, France | Closed | |||
 MILVUEDeveloped an artificial intelligence software to aid in radiological diagnosis |
Paris, France | Operational | |||
 AZmedThe first French company to commercialize an AI-powered radiology software |
Paris, France | Operational | |||
 ThironaDeveloping software solutions for automated medical image analysis |
Nijmegen, Netherlands | Operational | |||
 OptellumDeveloping an artificial intelligence software platform to support clinicians in lung cancer nodule management |
Oxford, United Kingdom | Operational | |||
 Deepeye MedicalPrecision health platform to improve therapy against blindness using AI |
Munich, Germany | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Verve Ventures
Swiss Entrepreneurs Foundation
Swisscom Ventures
Swisscanto Invest
Other known investors3 additional known investors
EFI Lake Geneva Ventures
Fa Diese
FONGIT
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medimaps Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medimaps Group’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.